iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Unusually-High Trading Volume – Should You Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw an uptick in trading volume on Thursday . 218,321 shares changed hands during trading, an increase of 270% from the previous session’s volume of 58,936 shares.The stock last traded at $67.62 and had previously closed at $67.54.

iShares U.S. Pharmaceuticals ETF Trading Down 0.3 %

The stock’s 50 day moving average price is $69.30 and its two-hundred day moving average price is $69.01. The firm has a market capitalization of $675.89 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

Several institutional investors have recently modified their holdings of IHE. Aptus Capital Advisors LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the second quarter valued at about $12,165,000. Rockport Wealth LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth approximately $12,091,000. Southern Capital Advisors LLC lifted its stake in iShares U.S. Pharmaceuticals ETF by 1.1% in the 3rd quarter. Southern Capital Advisors LLC now owns 40,280 shares of the company’s stock valued at $2,844,000 after buying an additional 448 shares in the last quarter. Commonwealth Equity Services LLC grew its holdings in iShares U.S. Pharmaceuticals ETF by 7.3% during the 2nd quarter. Commonwealth Equity Services LLC now owns 38,172 shares of the company’s stock valued at $2,532,000 after buying an additional 2,589 shares during the last quarter. Finally, Thrivent Financial for Lutherans increased its position in iShares U.S. Pharmaceuticals ETF by 23.6% during the third quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock worth $2,295,000 after buying an additional 6,214 shares in the last quarter.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.